CN Patent

CN116621918B — 一种螺环化合物及其制备方法与应用

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2023-10-31 · 3y expired

What this patent protects

本申请属于化学药物技术领域，涉及一种螺环化合物或其可药用的盐，及其制备方法与应用。所述化合物为3C样蛋白酶抑制剂，用于新冠感染等病症。

USPTO Abstract

本申请属于化学药物技术领域，涉及一种螺环化合物或其可药用的盐，及其制备方法与应用。所述化合物为3C样蛋白酶抑制剂，用于新冠感染等病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN116621918B
Jurisdiction
CN
Classification
—
Expires
2023-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Salubris Pharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.